Changyu Wang

6.6k citations
79 papers · 5.1k · 2 hit papers · h-index 25

Impact in

  • Oncology top 0.5%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
    • Colorectal Cancer Treatments and Studies
  • Immunology top 1%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology

Papers in

    • RNA Research and Splicing 4
    • RNA modifications and cancer 4
    • Cancer Immunotherapy and Biomarkers 9

Changyu Wang

76 papers receiving 5.0k citations

Changyu Wang's Hit Papers

In Vitro Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and In Vivo Toxicology in Non-Human Primates 2014 · 492 citations
4920+5+10Years since publication50010001.5k2.0k

Peers

Changyu Wang
Comparison fields: 5 of 114
  • Oncology 2.9k
  • Immunology 1.8k
  • Obstetrics and Gynecology 173
  • Cancer Research 297
  • Pulmonary and Respiratory Medicine 617
Replace María E. Rodríguez-Ruiz with:
María E. Rodríguez-Ruiz Spain
Yutaka Suehiro Japan
Hua Liang China
Alfredo Perales‐Puchalt United States
Suguru Yonezawa Japan
Nikolai N. Khodarev United States
Xiuli Wang China
Lana E. Kandalaft Switzerland
Barry M. Kacinski United States
Arko Gorter Netherlands
Changyu Wang relative to María E. Rodríguez-Ruiz Spain María E. Rodríguez-Ruiz's profile →
Citations per field
00.5×3.7×
María E. Rodríguez-Ruiz · 1×
Citations per year

Countries citing papers authored by Changyu Wang

Since Specialization
Citations

This map shows the geographic impact of Changyu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changyu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changyu Wang more than expected).

Fields of papers citing papers by Changyu Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changyu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changyu Wang. The network helps show where Changyu Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Changyu Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Changyu Wang Line = papers co-authored together Changyu Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
Hit paper breakdown →
20102421
2
In Vitro Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and In Vivo Toxicology in Non-Human Primates
Hit paper breakdown →
2014492
3 2018192
4 2016181
5 1999175
6 2009162
7 1995162
8 1998158
9 200985
10 200866
11 201360
12 201348
13 202148
14 200743
15 201743
16 202141
17 200840
18 202336
19 201634
20 201234

About Changyu Wang

Changyu Wang is a scholar working on Molecular Biology, Oncology, Immunology, Obstetrics and Gynecology and Reproductive Medicine, having authored 79 papers that have together received 5.1k indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (10 papers), Cancer Immunotherapy and Biomarkers (9 papers), Ovarian cancer diagnosis and treatment (8 papers), RNA Research and Splicing (4 papers), Immunotherapy and Immune Responses (4 papers), Ferroptosis and cancer prognosis (4 papers), RNA modifications and cancer (4 papers) and Immune cells in cancer (3 papers). The work is most often cited by research in Oncology (2.9k citations), Immunology (1.8k citations), Obstetrics and Gynecology (173 citations), Cancer Research (297 citations) and Pulmonary and Respiratory Medicine (617 citations). Changyu Wang has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Alan J. Korman, Mark Selby, Drew M. Pardoll, Suzanne L. Topalian, Alice Pons, Ira Wollner, Tracee L. McMiller, Elizabeth Stankevich, Theresa M. Salay and Lieping Chen. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology, International Journal of Gynecological Cancer, Agronomy and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact